You are here: Home » News-IANS » Health-Medicine
Business Standard

Dengue costs the world $8.9 bn annually

IANS  |  New York 

Dengue imposes a whopping $8.9 billion economic burden every year on 141 countries and territories where active transmission of the disease has been identified, a new study says.

"Our global estimates suggest that in 2013 there were a total of 58·40 million symptomatic dengue virus infections, including 13,586 fatal cases and that the total annual global cost of dengue illness was $8·9 billion," said the study published in the Lancet Infectious Diseases journal.

Dengue is the world's fastest growing mosquito-borne disease, currently threatening about half the world's population and leading to an estimated 60-100 million symptomatic dengue cases every year.

The disease tend to hit hardest in the urban growth centres of endemic countries, like India, Indonesia, and Brazil.

At an estimated cost of $8.9 billion annually, the price tag for dengue exceeds that of several other major infectious diseases such as cholera, rotavirus gastroenteritis, canine rabies and Chagas, noted lead study author Donald Shepard from Brandeis University, Waltham, Massachusetts, US.

Since it is transmitted by four distinct types of viruses, dengue can hit the same individual up to four times.

In this way, dengue can literally break the back of local healthcare systems and lead to intensive associated costs, related both to medical care and lost productivity.

The researchers took a comprehensive view to assemble all existing evidence to generate a systematic estimate of global economic burden.

"The dearth of population-based data for many elements was the biggest challenge of us. For important parts of the tropics-especially South Asia and Africa-almost no such studies exist, in fact," Shepard noted.

The researchers used the latest dengue incidence estimates from the Institute for Health Metrics and Evaluation's Global Burden of Disease Study 2013 and several other data sources to assess the economic burden of symptomatic dengue cases in the 141 countries and territories with active dengue transmission.

The Institute for Health Metrics and Evaluation is an independent global health research center at the University of Washington that provides rigorous and comparable measurement of the world's most important health problems.

"From the scientific literature and regressions, we estimated cases and costs by setting, including the non-medical setting, for all countries and territories," the researchers explained.

--IANS

gb/vm

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, May 05 2016. 11:06 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU